Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership29,726,052 shares
Latest Disclosed Value $ 4,135,590,576
Geode Capital Management, Llc reports 0.10% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 29,726,052 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,135,590,576 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 29,696,002 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 29,726,052 30,050 0.10 4,135,591 13.70 0.1375
2026-02-09 2025-12-31 13F GILEAD SCIENCES COM 375558103 29,696,002 -232,984 -0.78 3,637,369 9.91 0.2245
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 29,928,986 721,324 2.47 3,309,304 2.41 0.2111
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 29,207,662 727,515 2.55 3,231,548 1.38 0.2265
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 28,480,147 190,230 0.67 3,187,712 22.21 0.2506
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 28,289,917 749,047 2.72 2,608,337 13.30 0.2021
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 27,540,870 574,421 2.13 2,302,119 24.72 0.1864
2024-08-09 2024-06-30 13F GILEAD SCIENCES COM 375558103 26,966,449 617,094 2.34 1,845,901 -4.14 0.1620
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 26,349,355 1,075,170 4.25 1,925,650 -5.73 0.1781
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 25,274,185 578,546 2.34 2,042,622 10.57 0.2137
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 24,695,639 483,003 1.99 1,847,339 -0.75 0.2200
2023-08-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 24,212,636 447,585 1.88 1,861,363 -5.40 0.2187
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 23,765,051 -83,426 -0.35 1,967,701 96,167.17 0.2555
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 23,848,477 244,886 1.04 2,044 -99.86 0.2869
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 23,603,591 431,016 1.86 1,454,960 1.76 0.2207
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 23,172,575 468,908 2.07 1,429,762 6.19 0.2094
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 22,703,667 -35,512 -0.16 1,346,466 -18.25 0.1681
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 22,739,179 440,695 1.98 1,647,123 6.02 0.1984
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 22,298,484 383,163 1.75 1,553,614 3.19 0.2092
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 21,915,321 1,244,015 6.02 1,505,514 12.96 0.2074
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 20,671,306 592,386 2.95 1,332,764 14.20 0.2039
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 20,078,920 76,942 0.38 1,167,009 -7.51 0.1959
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 20,001,978 336,543 1.71 1,261,706 -16.49 0.2472
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 19,665,435 -217,073 -1.09 1,510,875 1.79 0.3232
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 19,882,508 658,471 3.43 1,484,311 19.04 0.3868
2020-02-20 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 19,224,037 535,813 2.87 1,246,933 5.41 0.2606
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 19,224,037 535,813 1,246,933 158,910.6776
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 18,688,224 315,436 1.72 1,182,957 -4.56 0.2761
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 18,372,788 751,923 4.27 1,239,438 8.36 0.2999
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM 375558103 17,620,865 753,800 4.47 1,143,817 8.59 0.2964
2019-03-06 2018-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 16,867,065 835,915 5.21 1,053,332 -14.74 0.3256
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 16,867,065 835,915 1,053,332
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 16,031,150 96,590 0.61 1,235,503 9.67 0.3481
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 15,934,560 -1,093,008 -6.42 1,126,604 -12.06 0.3463
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 17,027,568 1,178,505 7.44 1,281,045 13.03 0.4174
2018-02-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 15,849,063 379,867 2.46 1,133,346 -9.42 0.3849
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 15,469,196 375,993 2.49 1,251,197 17.29 0.4618
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 15,093,203 676,105 4.69 1,066,722 9.07 0.4195
2017-06-21 2017-03-31 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 14,417,098 1,071,094 8.03 977,973 2.44 0.4012
2017-05-12 2017-03-31 13F GILEAD SCIENCES INC COM COM 375558103 14,417,098 977,973
2017-02-14 2016-12-31 13F GILEAD SCIENCES INC COM COM 375558103 13,346,004 637,314 5.01 954,678 -4.92 0.4440
2016-11-10 2016-09-30 13F GILEAD SCIENCES INC COM COM 375558103 12,708,690 466,974 3.81 1,004,077 -1.52 0.5056
2016-08-12 2016-06-30 13F GILEAD SCIENCES INC COM COM 375558103 12,241,716 -169,130 -1.36 1,019,601 -10.40 0.5545
2016-05-13 2016-03-31 13F GILEAD SCIENCES INC COM COM 375558103 12,410,846 161,505 1.32 1,137,969 -8.01 0.6039
2016-02-12 2015-12-31 13F GILEAD SCIENCES INC COM COM 375558103 12,249,341 104,895 0.86 1,237,080 3.94 0.7050
2015-11-13 2015-09-30 13F GILEAD SCIENCES INC COM COM 375558103 12,144,446 108,350 0.90 1,190,216 -15.38 0.7219
2015-08-14 2015-06-30 13F GILEAD SCIENCES INC COM COM 375558103 12,036,096 -142,972 -1.17 1,406,506 17.86 0.8030
2015-05-14 2015-03-31 13F GILEAD SCIENCES INC COM COM 375558103 12,179,068 313,628 2.64 1,193,342 6.83 0.6821
2015-02-12 2014-12-31 13F GILEAD SCIENCES INC COM COM 375558103 11,865,440 463,779 4.07 1,117,056 -7.85 0.6646
2014-11-14 2014-09-30 13F GILEAD SCIENCES INC COM COM 375558103 11,401,661 -201,929 -1.74 1,212,201 26.07 0.7858
2014-08-13 2014-06-30 13F GILEAD SCIENCES INC COM COM 375558103 11,603,590 -135,653 -1.16 961,498 15.63 0.6216
2014-05-14 2014-03-31 13F GILEAD SCIENCES INC COM COM 375558103 11,739,243 232,536 2.02 831,499 -3.82 0.5578
2014-02-14 2013-12-31 13F GILEAD SCIENCES INC COM COM 375558103 11,506,707 409,251 3.69 864,482 23.99 0.5993
2013-11-14 2013-09-30 13F GILEAD SCIENCES INC COM COM 375558103 11,097,456 380,141 3.55 697,197 27.06 0.5590
2013-08-14 2013-06-30 13F GILEAD SCIENCES INC COM COM 375558103 10,717,315 10,717,315 548,723 0.4824
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.